| Dr Dornechia Elverna George Carter, MD | |
|
13136 Dallas Pkwy Ste 520, Frisco, TX 75033-4247 | |
| (469) 480-8100 | |
| (469) 480-8101 |
| Full Name | Dr Dornechia Elverna George Carter |
|---|---|
| Gender | Female |
| Speciality | Dermatology |
| Experience | 18 Years |
| Location | 13136 Dallas Pkwy Ste 520, Frisco, Texas |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1356503544 | NPI | - | NPPES |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Affinity Dermatology Pllc | 4688088529 | 3 |
News Archive
Children in U.S. households where English is not the primary language experience multiple disparities in health care, a UT Southwestern Medical Center researcher has found.
Costs associated with the health law are snarling contract negotiations around the country and causing problems for the infamous farm workers union health plan.
AstraZeneca and Targacept, Inc. today announced top-line results from the second of four RENAISSANCE Phase 3 studies investigating the efficacy and tolerability of TC-5214 as an adjunct therapy to an antidepressant in patients with major depressive disorder (MDD) who do not respond adequately to initial antidepressant treatment.
The 43 speakers in two meetings today - on resources mobilization and an enabling environment for poverty eradication - recognized that the primary responsibility for development in the least developed countries (LDCs) rested with those nations themselves.
NeuroVive, a leading mitochondrial medicine company, is presenting a breakthrough in the company's work on energy regulation at the cellular level.
› Verified 3 days ago
| Entity Name | Affinity Dermatology Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1205461019 PECOS PAC ID: 4688088529 Enrollment ID: O20210204000472 |
News Archive
Children in U.S. households where English is not the primary language experience multiple disparities in health care, a UT Southwestern Medical Center researcher has found.
Costs associated with the health law are snarling contract negotiations around the country and causing problems for the infamous farm workers union health plan.
AstraZeneca and Targacept, Inc. today announced top-line results from the second of four RENAISSANCE Phase 3 studies investigating the efficacy and tolerability of TC-5214 as an adjunct therapy to an antidepressant in patients with major depressive disorder (MDD) who do not respond adequately to initial antidepressant treatment.
The 43 speakers in two meetings today - on resources mobilization and an enabling environment for poverty eradication - recognized that the primary responsibility for development in the least developed countries (LDCs) rested with those nations themselves.
NeuroVive, a leading mitochondrial medicine company, is presenting a breakthrough in the company's work on energy regulation at the cellular level.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Dornechia Elverna George Carter, MD 13136 Dallas Pkwy Ste 520, Frisco, TX 75033-4247 Ph: (469) 480-8100 | Dr Dornechia Elverna George Carter, MD 13136 Dallas Pkwy Ste 520, Frisco, TX 75033-4247 Ph: (469) 480-8100 |
News Archive
Children in U.S. households where English is not the primary language experience multiple disparities in health care, a UT Southwestern Medical Center researcher has found.
Costs associated with the health law are snarling contract negotiations around the country and causing problems for the infamous farm workers union health plan.
AstraZeneca and Targacept, Inc. today announced top-line results from the second of four RENAISSANCE Phase 3 studies investigating the efficacy and tolerability of TC-5214 as an adjunct therapy to an antidepressant in patients with major depressive disorder (MDD) who do not respond adequately to initial antidepressant treatment.
The 43 speakers in two meetings today - on resources mobilization and an enabling environment for poverty eradication - recognized that the primary responsibility for development in the least developed countries (LDCs) rested with those nations themselves.
NeuroVive, a leading mitochondrial medicine company, is presenting a breakthrough in the company's work on energy regulation at the cellular level.
› Verified 3 days ago
Dr. Amanda Hope Champlain, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 4685 Eldorado Pkwy Ste 100, Frisco, TX 75033 Phone: 972-335-2727 Fax: 972-668-8444 | |
Dr. Carla Gustovich, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 13192 Dallas Pkwy Ste 620, Frisco, TX 75033 Phone: 972-668-3376 Fax: 972-668-7546 | |
Rachel Heather Quinby-graves, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 13192 Dallas Pkwy Ste 620, Frisco, TX 75033 Phone: 972-668-3376 Fax: 972-668-7546 | |
Dr. Lucy Li, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 9191 Kyser Way Bldg 3 Ste B, Frisco, TX 75034 Phone: 972-712-3131 Fax: 972-712-7171 | |
Dr. Timothy Rodgers, Dermatology Medicare: Accepting Medicare Assignments Practice Location: 3880 Parkwood Blvd, Suite 102, Frisco, TX 75034 Phone: 972-704-2400 | |
Dr. Jennifer Warner Dharamsi, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 3140 Legacy Drive, Suite 110, Frisco, TX 75034 Phone: 972-469-2626 Fax: 972-469-2818 | |
Rachael Free Earnest, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 3140 Legacy Dr Ste 110, Frisco, TX 75034 Phone: 972-469-2626 Fax: 972-469-2818 |